| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.29 | 4e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.26 | 6e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.21 | 6e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.27 | 1e-05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |